Patients with treatment resistant depression use more resources and have significantly higher health care costs, according to a retrospective cohort published in JMCP.
Patients with treatment resistant depression use more resources and have significantly higher health care costs, according to a retrospective cohort published in JMCP.
A cost impact analysis of Medicare patients with Alzheimer's disease and dementia in their final years of life found that families and Medicaid bear the bear most of the cost burden. The authors of this JMCP article propose the need to better integrate Medicare and Medicaid to fund and improve patient outcomes.
Where We Stand: The Academy of Managed Care Pharmacy (AMCP) supports scientifically sound research that compares the effectiveness and value of prescription drugs, as well as research aimed at tailoring treatment options to individual patients’ needs.
In diabetic patients, treatment intensification with insulin or GLP-1RA after failure of two oral anti-diabetic agents resulted in improved glycemic control, according to a retrospective cohort published in JMCP.
In diabetic patients, treatment intensification with insulin or GLP-1RA after failure of two oral anti-diabetic agents resulted in improved glycemic control, according to a retrospective cohort published in JMCP.
HIV positive patients on single tablet regimens have better adherence and lower inpatient health costs, according to a retrospective claims data analysis published in JMCP.